Requiring certain cost-sharing assistance be applied toward a covered individual's deductible or annual out-of-pocket limit under the individual's health benefit plan.
Died in Committee
Email me when SB 423 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 423. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would make any amount paid for a prescription drug—by the patient or a third party—count toward the individual’s deductible or annual out‑of‑pocket maximum when the drug has no generic or biosimilar equivalent, or when a brand‑name drug is used after prior authorization or step‑therapy. It applies to health insurers, pharmacy benefit managers and pharmacy‑administrative service organizations, affecting Kansas residents with health plans. The goal is to reduce the amount patients must pay before insurance coverage begins.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 423
3 free questions a day, no accountHistory
- Died in Committee
- Referred to Senate Committee on Financial Institutions and Insurance
- Introduced
Sponsors
- Dinah Sykes · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 423 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 423 freeOr ask your AI assistant about SB 423 directly:
Add to Claude, ChatGPT or Cursor